How to Help Your Patients Save Money on Nexlizet: A Provider's Guide to Savings Programs

One of the most common reasons patients fail to fill — or continue to fill — a Nexlizet prescription is cost. At $430-$595 per 30-day supply at full retail price, Nexlizet requires either solid insurance coverage or active engagement with savings programs. As a prescriber, you have significant leverage to help patients navigate these financial barriers. This guide covers every savings pathway available for Nexlizet and practical strategies to incorporate them into your practice workflow.

Why Cost Adherence Matters for Nexlizet Patients

Nexlizet is prescribed for chronic disease management — high LDL cholesterol and cardiovascular risk reduction. Gaps in therapy result in rebounding LDL levels and may increase cardiovascular event risk. Unlike a short-course antibiotic, Nexlizet is intended as lifelong therapy. This means cost is not a one-time hurdle; it's a recurring challenge at every refill.

Cost abandonment — when a patient receives a prescription but doesn't fill it due to price — is a well-documented barrier to statin and non-statin lipid therapy adherence. For Nexlizet specifically, the brand-only status and high retail price make this a significant issue without proactive intervention.

Savings Option 1: The Esperion NEXSTEP Copay Card ($10/fill for Eligible Patients)

The most impactful savings tool for commercially insured patients is the Esperion NEXSTEP Copay Card program:

Benefit: Eligible commercially insured patients may pay as little as $10 per Nexlizet fill

Who qualifies: US residents with commercial prescription drug insurance (employer or individual market). Excludes Medicare, Medicaid, TRICARE, VA healthcare.

Enrollment: Patients enroll at www.NexCopay.com or call 855-699-8814

Duration: One-year eligibility; patients must re-enroll annually

Samples available: Providers can request free 14-day samples of Nexlizet through Esperion to bridge patients while copay card enrollment processes

Important clinical note: The copay card may not be effective for patients with certain plan designs where copay card payments don't count toward deductibles or copays. Some HDHP-paired plans and specialty pharmacy carve-outs may exclude the card's benefit. Check with your medical assistant or the Esperion NEXSTEP team for plan-specific guidance.

Savings Option 2: Prior Authorization — Get It Right the First Time

Effective prior authorization is often the most critical factor in reducing patient cost. When PA is approved, patients often access Nexlizet at their standard specialist or non-preferred brand tier copay — far less than the full retail price. Strategies to improve first-pass PA approval:

Document statin intolerance explicitly: Note which statins were tried, at what doses, and what adverse effects occurred (myalgia, elevated CK, rhabdomyolysis)

Include step therapy documentation: If the patient has tried ezetimibe monotherapy without achieving their LDL target, document this failure. Most plans accept this as step therapy fulfillment.

Reference the CLEAR Outcomes data: For high-risk cardiovascular patients, citing the CLEAR Outcomes trial results (23% MI reduction, 19% revascularization reduction) strengthens the medical necessity argument for Nexlizet over cheaper alternatives.

Use Esperion's NEXSTEP Navigator: Contact navigator@esperion.com for PA support materials, appeal letter templates, and real-time status tracking.

Savings Option 3: GoodRx — For Uninsured and Underinsured Patients

For patients without commercial insurance — or those whose insurance doesn't cover Nexlizet — GoodRx coupons can reduce the cash price to approximately $231 for a 30-day supply (about 55% off retail). While still expensive, this is a meaningful reduction for patients who need Nexlizet urgently.

Counsel patients to search for the lowest GoodRx price at pharmacies near them — prices can vary by location and pharmacy chain. Costco and Walmart often show the lowest GoodRx rates. Other discount services (SingleCare, RxSaver) may offer similar or slightly different prices.

Savings Option 4: Medicare Part D Optimization

Nexlizet has achieved coverage on plans reaching 34 million Medicare lives (65% of the Medicare population). However, Medicare Part D plan formulary placement varies significantly. Strategies to help Medicare patients:

Verify plan-specific formulary status using CMS Plan Finder (medicare.gov/plan-compare) during open enrollment

Submit formulary exceptions with documented medical necessity — citing statin intolerance history and failed alternatives

As of 2026, Medicare Part D has a $2,100 annual out-of-pocket cap for covered medications — this limits Nexlizet cost even for plans with high initial copays once the patient reaches their OOP max

Remind patients: Medicare patients are not eligible for the Esperion Copay Card

Savings Option 5: 90-Day Supply for Long-Term Patients

For maintenance patients who are stable on Nexlizet, write prescriptions for a 90-day supply through mail-order pharmacy whenever the plan allows. Benefits include:

Lower per-dose cost on many insurance plans

Reduced pharmacy access burden — especially important for patients who struggle to find Nexlizet at retail pharmacies

Better adherence outcomes — 90-day supplies are associated with higher medication adherence rates compared to 30-day fills

When Cost Is an Insurmountable Barrier: Discussing Therapeutic Alternatives

When all savings options are exhausted and Nexlizet remains financially inaccessible for a patient, discuss therapeutic alternatives rather than leaving them without lipid-lowering therapy:

Generic ezetimibe (10 mg/day): $10-$30/month; provides the intestinal absorption inhibition component of Nexlizet

Lower-dose or different statin: Some previously statin-intolerant patients may tolerate a low-dose rosuvastatin (5 mg) or pravastatin; generics available at $5-$15/month

PCSK9 inhibitors with manufacturer programs: Amgen and Sanofi both have patient assistance programs for Repatha and Praluent for qualifying uninsured or underinsured patients

For more resources on patient access support, visit medfinder.com/providers — medfinder helps patients locate pharmacies with Nexlizet in stock near them, complementing your prescribing and access support workflow.

For more on Nexlizet availability and clinical context, see: Nexlizet shortage: what providers need to know in 2026.